Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 11:36 PM
Study NCT ID:
NCT00206193
Status:
UNKNOWN
Last Update Posted:
2007-10-30
First Post:
2005-09-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'interventionBrowseModule': {'meshes': [{'id': 'D015735', 'term': 'Mifepristone'}, {'id': 'D016595', 'term': 'Misoprostol'}, {'id': 'C016767', 'term': 'sulprostone'}], 'ancestors': [{'id': 'D004963', 'term': 'Estrenes'}, {'id': 'D004962', 'term': 'Estranes'}, {'id': 'D013256', 'term': 'Steroids'}, {'id': 'D000072473', 'term': 'Fused-Ring Compounds'}, {'id': 'D011083', 'term': 'Polycyclic Compounds'}, {'id': 'D011459', 'term': 'Prostaglandins E, Synthetic'}, {'id': 'D011465', 'term': 'Prostaglandins, Synthetic'}, {'id': 'D011453', 'term': 'Prostaglandins'}, {'id': 'D015777', 'term': 'Eicosanoids'}, {'id': 'D005231', 'term': 'Fatty Acids, Unsaturated'}, {'id': 'D005227', 'term': 'Fatty Acids'}, {'id': 'D008055', 'term': 'Lipids'}, {'id': 'D012898', 'term': 'Autacoids'}, {'id': 'D018836', 'term': 'Inflammation Mediators'}, {'id': 'D001685', 'term': 'Biological Factors'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE'}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'statusVerifiedDate': '2005-09', 'lastUpdateSubmitDate': '2007-10-29', 'studyFirstSubmitDate': '2005-09-13', 'studyFirstSubmitQcDate': '2005-09-13', 'lastUpdatePostDateStruct': {'date': '2007-10-30', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2005-09-21', 'type': 'ESTIMATED'}}, 'conditionsModule': {'keywords': ['termination of pregnancy'], 'conditions': ['Abortion, Induced']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.'}, 'eligibilityModule': {'sex': 'FEMALE', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Pregnant women by whom a termination of pregnancy is desired.\n\nExclusion Criteria:\n\n* Women with liver/kidney disease\n* Women on long-term use of corticosteroids (\\> 6 months)\n* Cardiovascular problems\n* Therapy-resistant diabetic women\n* Therapy-resistant asthma/bronchitis\n* Thalassemia\n* Ulcerative colitis\n* Peptic ulcer disease\n* Glaucoma\n* Porphyria\n* Allergic reaction to prostaglandin or mifepristone\n* Women with a prior caesarian section or women with contractions at the start of the study'}, 'identificationModule': {'nctId': 'NCT00206193', 'briefTitle': 'Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone', 'organization': {'class': 'OTHER', 'fullName': 'Atrium Medical Center'}, 'orgStudyIdInfo': {'id': 'TOP-protocol'}}, 'armsInterventionsModule': {'interventions': [{'name': 'mifepristone', 'type': 'DRUG'}, {'name': 'misoprostol', 'type': 'DRUG'}, {'name': 'sulprostone', 'type': 'DRUG'}]}, 'contactsLocationsModule': {'locations': [{'city': 'Heerlen', 'state': 'Limburg', 'status': 'RECRUITING', 'country': 'Netherlands', 'contacts': [{'name': 'Suzanne HW Vonken, Dr.', 'role': 'CONTACT', 'phone': '045-5766666(6825)'}, {'name': 'Suzanne HW Vonken, Dr.', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Atrium Medisch Centrum', 'geoPoint': {'lat': 50.88365, 'lon': 5.98154}}], 'centralContacts': [{'name': 'Suzanne HW Vonken, Dr.', 'role': 'CONTACT', 'email': 'svonken@gmail.com', 'phone': '003145-5766666', 'phoneExt': '466825'}, {'name': 'F Roumen, Dr.', 'role': 'CONTACT', 'phone': '003145-5766666', 'phoneExt': '466509'}], 'overallOfficials': [{'name': 'F Roumen, Dr.', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Atrium Medisch Centrum, Heerlen'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Atrium Medical Center', 'class': 'OTHER'}}}}